PulseAugur
EN
LIVE 13:08:32
中文(ZH) 维康药业:公司产品中选全国中成药采购联盟集中带量采购

Wahaha Group Personnel Changes; Musk's $780B Pay; Iran-US Talks Paused

Wecome Pharmaceutical announced that its product, Ganmao Qingre Granules, has been selected for a national centralized procurement of traditional Chinese medicine. Separately, Hangzhou Wahaha Group Co., Ltd. has seen changes in its key personnel, with new appointments and resignations affecting its directorship and supervisory roles, potentially indicating shifts in the company's management structure. In other news, Elon Musk's compensation package reached a staggering $780 billion, Iran has paused negotiations with the US due to threats from Donald Trump, and Liu Qiangdong stated that future logistics will not require delivery personnel, aiming to preserve jobs. AI

RANK_REASON The item is a digest of unrelated news items, with no single overarching theme or primary source.

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Wahaha Group Personnel Changes; Musk's $780B Pay; Iran-US Talks Paused

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Weikang Pharmaceutical: Company Products Selected for Centralized Volume-Based Procurement by the National Chinese Patent Medicine Procurement Alliance

    36氪获悉,维康药业公告,根据湖北医保服务平台于2026年6月17日发布的《关于公布全国中成药采购联盟集中采购中选结果的通知》,公司产品感冒清热颗粒中选本次全国中成药采购联盟集中带量采购。